In colon cancer cells, SFN treatment increased expression of the DBIRD complex members (Fig. 7A–D) and demonstrated a requirement for CCAR2 in the BAZ1A splicing mechanism (Fig. 7E, F). The gene discussed is BAZ1A; the disease is colonic neoplasm.